Fractional excretion of sodium

1. Empagliflozin increases fractional excretion of sodium in humans (+0.44 percentage points (95%CI: 0.05-0.83; p=0.029)).

   Human trialtype 2 diabetes, decompensated cirrhosis, and refractory ascites10 mg once daily10 daysn = 21

   Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study · Journal of gastrointestinal and liver diseases : JGLD · 26 Sep 2026

Empagliflozin →